Zobrazeno 1 - 10
of 30
pro vyhledávání: ''
Autor:
Tam N M Ngo, Jan Mazur, Eugene S. Chung, Huy Gia Vuong, Vien T. Truong, Vy T. Pham, Binh Q Truong, Quoc Bui, Cassady Palmer
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 24, Pp 8838-8845 (2021)
Cancer Medicine, Vol 10, Iss 24, Pp 8838-8845 (2021)
Background The survival outcome for primary cardiac malignant tumors (PMCTs) based on race has yet to be fully elucidated in previously published literature. This study aimed to address the general long‐term outcome and survival rate differences in
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7320-7329 (2021)
Cancer Medicine
Cancer Medicine
Background Previous studies have shown that marital status was associated with stages and survival in patients with melanoma or Merkel cell carcinoma. To date, the impacts of marital status on stage and survival in patients with mycosis fungoides (MF
Publikováno v:
Cancer Medicine, Vol 10, Iss 15, Pp 5338-5346 (2021)
Cancer Medicine
Cancer Medicine
Background Patients with prostate cancer (PC) are at a high risk of developing secondary hematologic malignancies (SHMs) after radiation therapy (RT), while no study has assessed the relationship of different treatment modalities with the occurrence
Autor:
Caitlin C. Murphy, Danyi Xiong, Bhumika Maddineni, Ethan A. Halm, David E. Gerber, Sandi L. Pruitt, Hong Zhu, Daniel F. Heitjan, Anna Tavakkoli, Amit G. Singal
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 14, Pp 4752-4767 (2021)
Cancer Medicine, Vol 10, Iss 14, Pp 4752-4767 (2021)
Patients with previous cancer are often excluded from clinical trials despite limited evidence about their prognosis. We examined the effect of previous cancer on overall and colorectal cancer (CRC)‐specific survival of patients newly diagnosed wit
Autor:
Fanfan Zhao, Fengshuo Xu, Qiao Huang, Chengzhuo Li, Xiaojie Feng, Jun Lyu, Shuai Zheng, Didi Han
Publikováno v:
Cancer Medicine, Vol 10, Iss 11, Pp 3756-3769 (2021)
Cancer Medicine
Cancer Medicine
Introduction Parotid‐gland carcinoma (PGC) is a relatively rare tumor that comprises a group of heterogeneous histologic subtypes. We used the Surveillance, Epidemiology, and End Results (SEER) program database to apply a competing‐risks analysis
Autor:
Guilan Xie, Liren Yang, Ruiqi Wang, Mei Chun Chung, Wenfang Yang, Liyan Huang, Li Shang, Cuifang Qi
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 10, Pp 3205-3213 (2021)
Cancer Medicine, Vol 10, Iss 10, Pp 3205-3213 (2021)
Background The incidence of endometrial cancer has tended to increase in recent years. However, competing risk nomogram combining comprehensive factors for endometrial cancer patients treated with hysterectomy is still scarce. Therefore, we aimed to
Autor:
Kevin Henderson, Anthony Masaquel, Deborah Morreall, Keith L Dawson, Catherine Li, Christina Yong, Ahmad Halwani, Vikas Patil, Brian C. Sauer, Elisha Delong-Sieg, Kelli M Rasmussen, Zachary Burningham
Publikováno v:
Cancer Medicine, Vol 9, Iss 20, Pp 7537-7547 (2020)
Cancer Medicine
Cancer Medicine
Real‐world practice patterns and clinical outcomes in patients with follicular lymphoma (FL), including the adoption of maintenance rituximab (MR) therapy in the United States (US), have been reported in few studies since the release of the Nationa
Publikováno v:
Cancer Medicine, Vol 9, Iss 16, Pp 5756-5766 (2020)
Cancer Medicine
Cancer Medicine
Introduction Unlike the established evidence to use chemotherapy for urothelial carcinoma of the bladder, presently there are insufficient data to inform a recommendation on upper urinary tract urothelial carcinoma treatment. The prognosis for patien
Publikováno v:
Cancer Medicine, Vol 9, Iss 16, Pp 6069-6075 (2020)
Cancer Medicine
Cancer Medicine
Background The incidence of male breast cancer (MBC), although rare, has shown an increase. However, the current epidemiology of and practice patterns for MBC remain unclear. This study evaluated the characteristics and care patterns for MBC compared
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 15, Pp 5381-5391 (2020)
Cancer Medicine, Vol 9, Iss 15, Pp 5381-5391 (2020)
Background Mucinous breast carcinoma (MBC) is a relatively rare pathological type of breast cancer. Compared with mastectomy in MBC, the effect and safety of breast‐conserving therapy (BCT) remains unclear. Therefore, we investigated the long‐ter